Coronavirus outbreak: Europe secures 400 million doses of Oxford vaccine from drug maker AstraZeneca

AstraZeneca has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal to pledge its drug to help combat the pandemic.The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said on Saturday, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic.Deliveries will start…

Read the original article at South China Morning Post